SYSGEN OF OBESITY
Systems Genetics of Obesity and Related Metabolic Traits in Pig Model to Improve Human Health
| Coordinatore | KOBENHAVNS UNIVERSITET
Organization address
postcode: 1017 contact info |
| Nazionalità Coordinatore | Denmark [DK] |
| Totale costo | 100˙000 € |
| EC contributo | 100˙000 € |
| Programma | FP7-PEOPLE
Specific programme "People" implementing the Seventh Framework Programme of the European Community for research, technological development and demonstration activities (2007 to 2013) |
| Code Call | FP7-PEOPLE-2011-CIG |
| Funding Scheme | MC-CIG |
| Anno di inizio | 2011 |
| Periodo (anno-mese-giorno) | 2011-09-01 - 2015-08-31 |
Partecipanti
| # | ||||
|---|---|---|---|---|
| 1 | KOBENHAVNS UNIVERSITET | DK | coordinator | 100˙000.00 |
Mappa
Word cloud
Esplora la "nuvola delle parole (Word Cloud) per avere un'idea di massima del progetto.
Obiettivo del progetto (Objective)
'The SysGen of Obesity project aims to use the pig as an animal model to unravel genes affecting human obesity, metabolic syndrome and diabetes (OMSD) traits and to catalogue their functional and molecular interactions and biological pathways. It uses state-of-the-art technologies and analytical approaches. The animal model uses a pig population of over 500 third generation progeny derived from crossing very divergent parental breeds (lean and fatty). It thus provides a very powerful design to map genes affecting OMSD. The resource population will be phenotyped for many traits including blood profiles known to be relevant to OMSD. Genotyping will be based on the Porcine 60k Illumina SNPchip. Gene or quantitative trait locus (QTL) mapping and genome-wide association studies (GWAS) will be conducted to detect genes and variants affecting OMSD traits. These genes will subsequently be validated for biological relevance using systems genetics approaches. They will also be screened for concordance with human QTL-GWAS results by comparative genomics. The most significant genes from the above steps could harbour relevant causal genes/mutations and hence will be selected for targeted resequencing and further analyses. This animal model is also expected to find 'novel' genes and pathways that have not been identified previously in human obesity. Systems biology experiment is planned using a ‘BioBank’ of relevant tissues and RNA samples from this resource population. The ultimate impact will be in the form of delivery of potential causal mutations, biological pathways, genetic- and bio-markers and new drug targets to improve human health. Hence our project will enhance EU excellence in Genetics and Systems Biology of OMSD and strengthen EU bio-medical industry. This grant will give an excellent opportunity for the researcher to conduct this high profile research thereby integrating him in EU scientific community and will significantly enhance his long-term career prospects'